Botanix Says European Patent Office Issues Intention to Grant Patent Covering Proprietary Applicator Technology, Shares Soar 18%
MT Newswires Live
Jul 07
Botanix Pharmaceuticals (ASX:BOT) said the European Patent Office issued an Intention to Grant a patent covering proprietary applicator technology used with its sofpironium topical gel product, which is known as Sofdra in the US, according to a Tuesday Australian bourse filing.
The patent covers relevant aspects of the applicator device utilized with the topical gel product, including features designed to support controlled topical administration and patient use.
The patent is expected to provide intellectual property protection until May 2039 after the formal grant process is completed.
Its shares soared 18% in recent trading on Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.